Histone deacetylase inhibitors decrease the antigen presenting activity of murine bone marrow derived dendritic cells

Cellular Immunology

Volumn 262, Issue 1, 2010, Pages 52-57

  Kim, Eun Sun ^a   Lee, Jae Kwon ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Antigen presentation; Dendritic cells; Histone deacetylase inhibitor; Immunesuppressor; Interleukin 2

Indexed keywords

6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; AUTACOID; BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; TRICHOSTATIN A;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; ENZYME IMMUNOASSAY; FLUORESCENCE ACTIVATED CELL SORTING; INFLAMMATION; INHIBITION KINETICS; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; HISTONE DEACETYLASE INHIBITORS; INTERLEUKIN-2; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL;

MURINAE;

EID: 77349124906     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.12.007     Document Type: Article

References (35)

1. Kuo M.H., and Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20 (1998) 615-626
2. Huang L. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases. J. Cell. Physiol. 209 (2006) 611-616
3. Marks P., Rifkind R.A., Richon V.M., Breslow R., Miller T., and Kelly W.K. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1 (2001) 194-202
4. Mishra N., Reilly C.M., Brown D.R., Ruiz P., and Gilkeson G.S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 111 (2003) 539-552
5. Leoni F., Zaliani A., Bertolini G., Porro G., Pagani P., Pozzi P., Dona G., Fossati G., Sozzani S., Azam T., Bufler P., Fantuzzi G., Goncharov I., Kim S.H., Pomerantz B.J., Reznikov L.L., Siegmund B., Dinarello C.A., and Mascagni P. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. USA 99 (2002) 2995-3000
6. Reddy P., Teshima T., Kukuruga M., Ordemann R., Liu C., Lowler K., and Ferrara J.L. Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J. Exp. Med. 194 (2001) 1433-1440
7. Chung Y.L., Lee M.Y., Wang A.J., and Yao L.F. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol. Ther. 8 (2003) 707-717
8. Nishida K., Komiyama T., Miyazawa S., Shen Z.N., Furumatsu T., Doi H., Yoshida A., Yamana J., Yamamura M., Ninomiya Y., Inoue H., and Asahara H. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression. Arthritis Rheum. 50 (2004) 3365-3376
9. Reilly C.M., Mishra N., Miller J.M., Joshi D., Ruiz P., Richon V.M., Marks P.A., and Gilkeson G.S. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J. Immunol. 173 (2004) 4171-4178
10. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
11. Sebastian C., Serra M., Yeramian A., Serrat N., Lloberas J., and Celada A. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. J. Immunol. 180 (2008) 5898-5906
12. Morgan M.M., Clayton C.C., and Heinricher M.M. Dissociation of hyperalgesia from fever following intracerebroventricular administration of interleukin-1beta in the rat. Brain Res. 1022 (2004) 96-100
13. Lee J.K., Lee M.K., Yun Y.P., Kim Y., Kim J.S., Kim Y.S., Kim K., Han S.S., and Lee C.K. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int. Immunopharmacol. 1 (2001) 1275-1284
14. Yoshida M., Kijima M., Akita M., and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265 (1990) 17174-17179
15. Guan R.J., Ford H.L., Fu Y., Li Y., Shaw L.M., and Pardee A.B. Drg-1 as a differentiation-related. Putative metastatic suppressor gene in human colon cancer, Cancer Res. 60 (2000) 749-755
16. Yu Z., Zhang W., and Kone B.C. Histone deacetylases augment cytokine induction of the iNOS gene. J. Am. Soc. Nephrol. 13 (2002) 2009-2017
17. Richon V.M., Webb Y., Merger R., Sheppard T., Jursic B., Ngo L., Civoli F., Breslow R., Rifkind R.A., and Marks P.A. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc. Natl. Acad. Sci. USA 93 (1996) 5705-5708
18. Mease P.J., Goffe B.S., Metz J., VanderStoep A., Finck B., and Burge D.J. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356 (2000) 385-390
19. Quah B.J., and O'Neill H.C. Maturation of function in dendritic cells for tolerance and immunity. J. Cell. Mol. Med. 9 (2005) 643-654
20. Chen Y.W., Shi R., Geraci N., Shrestha S., Gordish-Dressman H., and Pachman L.M. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC Immunol. 9 (2008) 43
21. Notarbartolo M., Poma P., Perri D., Dusonchet L., Cervello M., and D'Alessandro N. Antitumor effects of curcumin. Alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression, Cancer Lett. 224 (2005) 53-65
22. Sarkar S., and Fox D.A. Dendritic cells in rheumatoid arthritis. Front. Biosci. 10 (2005) 656-665
23. Zhuang H., Narain S., Sobel E., Lee P.Y., Nacionales D.C., Kelly K.M., Richards H.B., Segal M., Stewart C., Satoh M., and Reeves W.H. Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus. Clin. Immunol. 117 (2005) 238-250
24. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L.L., and Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366 (1993) 76-79
25. Austyn J.M. New insights into the mobilization and phagocytic activity of dendritic cells. J. Exp. Med. 183 (1996) 1287-1292
26. Granucci F., Ferrero E., Foti M., Aggujaro D., Vettoretto K., and Ricciardi-Castagnoli P. Early events in dendritic cell maturation induced by LPS. Microbes Infect. 1 (1999) 1079-1084
27. Zhang Y., Shlomchik W.D., Joe G., Louboutin J.P., Zhu J., Rivera A., Giannola D., and Emerson S.G. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J. Immunol. 169 (2002) 7111-7118
28. Merad M., Hoffmann P., Ranheim E., Slaymaker S., Manz M.G., Lira S.A., Charo I., Cook D.N., Weissman I.L., Strober S., and Engleman E.G. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10 (2004) 510-517
29. Moghaddami M., Cleland L.G., Radisic G., and Mayrhofer G. Recruitment of dendritic cells and macrophages during T cell-mediated synovial inflammation, Arthritis Res. Ther. 9 (2007) R120
30. Robb R.J., and Smith K.A. Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. Mol. Immunol. 18 (1981) 1087-1094
31. Stern J.B., and Smith K.A. Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science 233 (1986) 203-206
32. Beadling C., Johnson K.W., and Smith K.A. Isolation of interleukin 2-induced immediate-early genes. Proc. Natl. Acad. Sci. USA 90 (1993) 2719-2723
33. Beadling C., and Smith K.A. DNA array analysis of interleukin-2-regulated immediate/early genes. Med. Immunol. 1 (2002) 2
34. Schmidt K., Seeger K., Scheibenbogen C., Bender R., Abdulla M., Sussmilch S., Salama A., and Moldenhauer A. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia. J. Leukoc. Biol. 85 (2009) 563-573
35. Moldenhauer A., Frank R.C., Pinilla-Ibarz J., Holland G., Boccuni P., Scheinberg D.A., Salama A., Seeger K., Moore M.A., and Nimer S.D. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins. J. Leukoc. Biol. 76 (2004) 623-633